CRSP icon

CRISPR Therapeutics

444 hedge funds and large institutions have $3.21B invested in CRISPR Therapeutics in 2024 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 157 increasing their positions, 126 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
444
Holders Change
-36
Holders Change %
-7.5%
% of All Funds
6.46%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
49
Increased
157
Reduced
126
Closed
75
Calls
$127M
Puts
$119M
Net Calls
+$7.93M
Net Calls Change
-$36.1M
Name Holding Trade Value Shares
Change
Shares
Change %
MWM
401
Mascoma Wealth Management
New Hampshire
$2.21K
HGERS
402
Householder Group Estate & Retirement Specialist
Arizona
$2K
CT
403
Colonial Trust
South Carolina
$1.94K
AT
404
Arlington Trust
Alabama
$1.84K
LC
405
Lindbrook Capital
California
$1.73K
DF
406
Dunhill Financial
United Kingdom
$1.73K
ME
407
McIlrath & Eck
Washington
$1.67K
PP
408
Pacifica Partners
Canada
$1.62K
KA
409
Kozak & Associates
Colorado
$1.4K
CJ
410
Caitlin John
Michigan
$1.35K -$540 -10 -29%
GI
411
Gradient Investments
Minnesota
$1.35K
GFPC
412
Global Financial Private Client
Florida
$1.24K
VF
413
VitalStone Financial
Texas
$1.19K -$540 -10 -31%
IFAM
414
Institutional & Family Asset Management
Colorado
$1.13K
CWP
415
Concord Wealth Partners
Virginia
$1.08K -$594 -11 -35%
BIA
416
Bell Investment Advisors
California
$865 -$270 -5 -24%
GWP
417
Gen-Wealth Partners
Michigan
$864
APW
418
Atlantic Private Wealth
North Carolina
$810
RI
419
Ridgewood Investments
New Jersey
$810 +$810 +15 New
CIA
420
Cape Investment Advisory
Georgia
$810 +$810 +15 New
OP
421
ORG Partners
Indiana
$809 +$809 +15 New
Kayne Anderson Rudnick Investment Management
422
Kayne Anderson Rudnick Investment Management
California
$756
DI
423
DAGCO Inc
Ohio
$702
NSIM
424
North Star Investment Management
Illinois
$702
PS
425
PayPay Securities
Japan
$594 -$378 -7 -39%